0 Items
Select Page

Herpes Simplex

Herpes simplex virus (HSV-1) causes highly contagious infection, which is common and endemic throughout the world. Most HSV-1 infections are acquired during childhood, and infection is lifelong. The vast majority of HSV-1 infections are oral herpes, but a small proportion of HSV-1 infections may present as genital herpes. HSV-2 infection is widespread and is almost exclusively sexually transmitted, causing genital herpes. HSV-2 is the main cause of genital herpes and is lifelong and incurable.

The Native Antigen Company offers a range of both antigens and antibodies for research into both HSV-1 and HSV-2, including specific reagents that can distinguish between these infections.

Herpes Simplex Background

Human herpes simplex virus (HSV), also known as human herpes virus (HHV), is a large enveloped double stranded DNA virus that belongs to the Herpesviridae family, subfamily Alphaherpesvirinae. Human HSV exists as two distinct serotypes: herpes simplex virus type -1 (HSV-1 / HHV1) and type -2 (HSV-2 / HHV2). Both HSV-1 and HSV-2 are neurotrophic viruses that invade the central nervous system (CNS), where they replicate and have the capacity to establish a latent infection (Nicoll, MP et al).

HSV-1 and HSV-2 are primarily transmitted from human-to-human through contact with mucosal surfaces and damaged skin, which are common sites of primary HSV infection. However, the route and site of infection differs for each serotype with some reported overlap. Typically, HSV-1 is transmitted through oral-to-oral contact giving rise to infection of the lips, eyes and oropharyngeal mucosa, and can also present in the genital tract through oral-genital contact. HSV-2 tends to be sexually transmitted via contact with infected mucosa or damaged skin associated with the genital tract. In most cases, individuals infected with either HSV-1 or HSV-2 for the first time remain asymptomatic or present with painful blisters or ulcers at the site of infection.

HSV-1 establishes latency in the trigeminal ganglia, whereas HSV-2 tends to establish latency in the lumbar-sacral ganglia. Reactivation of either HSV-1 or HSV-2 can occur in immunosuppressed individuals or in seropositive individuals in response to a wide range of stimuli including periods of emotional and physical stress.

Both HSV-1 and HSV-2 are widespread, lifelong infections. Some symptoms of infection can be alleviated using antiviral medication, though no prophylactic vaccine currently exists for either HSV-1 or HSV-2 (WHO factsheet).

References

  1. Nicoll, MP et al. (2012). The molecular basis of herpes simplex virus latency. FEMS Microbiol Rev.36(3): 684–705.
  2. World Health Organisation – Herpes Simplex Virus factsheet

Herpes Simplex Antigens

We offer a range of native antigens for both HSV-1 and HSV-2. Virus preparations are derived from in vitro culture, with the option of a whole cell lysate or highly purified viral particles available. We also offer a preparation of purified gG2 protein, which is the only known protein that can serologically distinguish between HSV-1 and HSV-2 infections.

Herpes Simplex Antibodies

Our range of antibodies specific to herpes simplex virus includes reagents specific for glycoprotein D, which bind to both HSV-1 and HSV-2, and an antibody that is highly specific for HSV-2.  These inlcude antibodies validated as matched pairs in immunoassays.

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Why We Need Antigen and Antibody Tests for COVID-19

RT-PCR is the workhorse of viral diagnosis and has been invaluable in COVID-19 case confirmation and isolation guidance. However, while fast and sensitive, PCR suffers from some inherent drawbacks that limit it to diagnosis during the acute phase of infection. To...

Gonorrhea: What’s Currently in the Clinical Pipeline?

This article was written by our friends at Infectious Diseases Hub, a free-to-access website that aims to deliver up-to-date, essential research and information on all aspects of microbiology, virology, mycology and parasitology – from bench to bedside....

Novel Coronavirus Antigens Now Available

The Native Antigen Company is now offering recombinant S1 and S2 glycoproteins for SARS-CoV-2 (Covid-19) in response to urgent demand. These reagents are suitable for use in basic research and the development of diagnostics and vaccines.These antigens have been...

The Why and How of Protein Conjugation

In this blog, Lead Assay Development Scientist, Toni Ertl discusses the basics of protein conjugation and introduces our new range of conjugation kits for the labelling of antigens and antibodies.Detecting Proteins If you’re trying to detect or measure the presence...

Going Viral: Why We Need New Diagnostics For a Safe and Effective Dengue Vaccine

This article is taken from European Biopharmaceutical Review January 2020, pages 44-46. © Samedan Ltd.The Dengue VirusDengue is the world’s most prevalent and consequential arboviral disease. Current estimates indicate that as many as 390 million dengue infections...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

13 + 15 =

Live Customer Feedback

Join our mailing list

* indicates required